1 Min Read
Nov 15 (Reuters) - Actinogen Medical Ltd:
* Received an research and development tax incentive rebate of $1.22 million for 2016/2017 financial year Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.